I think, in the first order—and this is why I was pushing back—that we have a very serious problem, and that problem is that a huge number of Canadians don't have drug coverage.
If we're discussing how we address that problem, I'm totally open to different ideas. I think this process is indicative of that. We had two different parties with two different ideas try to come together and find common ground. If other parties have other ideas, then I think it's important to talk about them.
Frankly, if they have no idea and they just think people should continue to be uninsured, then yes, I'm going to point that out. I think that's important to highlight, and I don't think it is appropriate to try to obfuscate behind some kind of weird strategy.
What I will say in terms of the next steps, because this is critically important, is that we've already started those steps. There have been very productive conversations with every province and every territory. They have really set aside partisanship to ask, in each province and each jurisdiction, how we can work with that jurisdiction of authority to augment and make better what they have.
We have provinces that are leaders, so let's acknowledge Quebec, B.C., Nova Scotia, and Manitoba particularly, which are really taking leadership in this area. We want to see that go even further to be able to work with leaders and to be able to expand our circle of action.
What's exciting about that is that it's an example of governments of all political stripes recognizing that diabetes and contraceptives are not something that we should be crossing swords over or trying to score political points on, that it's really how we get the medicine to people who need it and how we talk about solutions. It could be quite frustrating when I'm talking to provinces about solutions to be curtailed from that.
Then I would add an additional measure. Obviously, to really finalize those conversations, we need the House to adopt this so that we can finish those conversations, but then I would turn to the non-insured health benefit. You were asking, very importantly, about indigenous peoples, and I think that this is an important opportunity, in conjunction with what we're doing with the non-insured health benefit, to consider its efficacy and make sure that everybody has access to the medicine that they need. That's an iterative process, and it has to be taken a step at a time.